hVIVO (HVO) Competitors GBX 10 -0.20 (-1.96%) As of 07/11/2025 11:49 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesBuy This Stock HVO vs. FARN, VRP, ARIX, CIR, BVXP, 4BB, AVCT, TILS, VSN, and SCLPShould you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Circassia Group (CIR), Bioventix (BVXP), 4basebio (4BB), Avacta Group (AVCT), Tiziana Life Sciences (TILS), Verseon (VSN), and Scancell (SCLP). These companies are all part of the "biotechnology" industry. hVIVO vs. Its Competitors Faron Pharmaceuticals Oy Verona Pharma plc (VRP.L) Arix Bioscience Circassia Group Bioventix 4basebio Avacta Group Tiziana Life Sciences Verseon Scancell Faron Pharmaceuticals Oy (LON:FARN) and hVIVO (LON:HVO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends. Do insiders and institutionals have more ownership in FARN or HVO? 10.7% of Faron Pharmaceuticals Oy shares are owned by institutional investors. Comparatively, 34.9% of hVIVO shares are owned by institutional investors. 31.8% of Faron Pharmaceuticals Oy shares are owned by insiders. Comparatively, 14.0% of hVIVO shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is FARN or HVO more profitable? hVIVO has a net margin of 25.96% compared to Faron Pharmaceuticals Oy's net margin of 0.00%. hVIVO's return on equity of 47.93% beat Faron Pharmaceuticals Oy's return on equity.Company Net Margins Return on Equity Return on Assets Faron Pharmaceuticals OyN/A 0.46% -70.00% hVIVO 25.96%47.93%11.97% Does the media prefer FARN or HVO? In the previous week, Faron Pharmaceuticals Oy had 2 more articles in the media than hVIVO. MarketBeat recorded 2 mentions for Faron Pharmaceuticals Oy and 0 mentions for hVIVO. Faron Pharmaceuticals Oy's average media sentiment score of 1.04 beat hVIVO's score of 0.00 indicating that Faron Pharmaceuticals Oy is being referred to more favorably in the media. Company Overall Sentiment Faron Pharmaceuticals Oy Positive hVIVO Neutral Which has higher earnings & valuation, FARN or HVO? hVIVO has higher revenue and earnings than Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFaron Pharmaceuticals OyN/AN/A-£60.23M-£37.39-5.42hVIVO£68.74M1.03£17.84M£2.424.12 Which has more volatility and risk, FARN or HVO? Faron Pharmaceuticals Oy has a beta of 0.36, indicating that its stock price is 64% less volatile than the S&P 500. Comparatively, hVIVO has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Do analysts rate FARN or HVO? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Faron Pharmaceuticals Oy 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00hVIVO 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryhVIVO beats Faron Pharmaceuticals Oy on 11 of the 14 factors compared between the two stocks. Get hVIVO News Delivered to You Automatically Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HVO vs. The Competition Export to ExcelMetrichVIVOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£70.76M£129.25M£5.62B£3.00BDividend Yield1.10%3.74%5.24%5.02%P/E Ratio4.123.4728.13150.83Price / Sales1.034,141.03428.26314,599.98Price / Cash4.9413.1937.4627.97Price / Book1.8042.088.044.58Net Income£17.84M-£92.15M£3.18B£5.90B7 Day Performance-6.98%1.38%3.62%11.51%1 Month Performance-13.04%4.52%4.06%7.92%1 Year Performance-62.83%174.83%30.01%32.01% hVIVO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HVOhVIVON/AGBX 10-2.0%N/A-63.4%£70.76M£68.74M4.12N/AGap UpFARNFaron Pharmaceuticals OyN/AGBX 214-0.5%N/A+60.1%£287.30MN/A-5.7234News CoveragePositive NewsGap DownVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,650-1.1%N/A-33.6%£138.76M£13.65M17.1412News Coverage4BB4basebio1.7036 of 5 starsGBX 1,005+0.5%GBX 1,600+59.2%-35.1%£128.74M£311K-1,288.46101News CoverageAVCTAvacta GroupN/AGBX 32+1.6%N/A-59.3%£121.57M£26.29M-4.12120TILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911VSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpSCLPScancellN/AGBX 10-3.8%N/A-7.9%£103.57MN/A-15.3351Gap Down Related Companies and Tools Related Companies FARN Competitors VRP Competitors ARIX Competitors CIR Competitors BVXP Competitors 4BB Competitors AVCT Competitors TILS Competitors VSN Competitors SCLP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HVO) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share hVIVO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
